10x Genomics (TXG) Tax Provisions (2018 - 2026)

10x Genomics has disclosed Tax Provisions across 9 years of filings, most recently posting $623000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $623000.0, down 26.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (down 6.19% YoY), and the FY2025 annual result was $3.6 million, down 26.18% from the prior year.
• Tax Provisions came in at $623000.0 for Q1 2026 at 10x Genomics, down from $1.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.5 million in Q2 2025 to a low of -$733000.0 in Q3 2025.
• The 5-year median for Tax Provisions is $1.1 million (2025), against an average of $1.2 million.
• Across the five-year window, Tax Provisions jumped 259.27% in 2022 and sank 155.74% in 2025, its largest moves.
• 10x Genomics' Tax Provisions stood at $804000.0 in 2022, then soared by 192.79% to $2.4 million in 2023, then sank by 72.47% to $648000.0 in 2024, then jumped by 63.43% to $1.1 million in 2025, then sank by 41.17% to $623000.0 in 2026.
• The last three Tax Provisions figures came in at $623000.0 (Q1 2026), $1.1 million (Q4 2025), and -$733000.0 (Q3 2025), per Business Quant data.